The U.S. Justice Department announced Tuesday that it has reached a settlement with long-term care pharmacy provider Omnicare Inc., ending an investigation into whether the company violated an anti-discrimination rule included in the Immigration and Nationality Act.
A federal court has found that Omnicare Inc. and its contractor, Act Fast Delivery, jointly employ a group of drivers under a year-old, co-employment standard.
Long-term care pharmacy giant Omnicare agreed to pay a total of $31 million in May to settle allegations it submitted false claims and accepted kickbacks to promote certain drugs.
Optimus EMR Inc. has been certified by the Ohio Board of Pharmacy for its bi-directional pharmacy interface using NCPDP 10.6 messages.
The Justice Department has filed a False Claims Act complaint against Omnicare Inc., alleging the pharmaceutical giant received millions in kickbacks from Abbott Laboratories over a 10-year period.
MatrixCare has received ePrescription transmission by the Ohio Board of Pharmacy, specifically for the use of its integration with Omnicare pharmacies, FrameworkLTC and QS1 pharmacy software solutions.
Optimus EMR Inc. announced in November it had made a transition with its pharmacy partners from HL7 to NCPDP Script 10.6 interfaces.
Omnicare Inc. and McKesson Corporation have signed an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals.
Supreme Court hears arguments over whether Omnicare misled investors ... Hospice medical director faces up to 20 years in prison for improper patient certifications ... Lack of interoperability is hindering accountable care organizations, ONC report says
Long-term care pharmacy Omnicare will not face False Claims Act penalties for drug packaging practices that apparently ran afoul of safety regulations. The U.S. Supreme Court has declined to take up the case, meaning that an appeals court ruling in Omnicare's favor will stand.
Medication management is as much art as science in a patient's final days, and that can present multifaceted caregiving challenges for hospice providers
A federal court in New York has tossed a whistleblower lawsuit charging that large long-term care pharmacies violated the False Claims Act by failing to dispense requested generic drugs.
The nation's largest long-term care pharmacy has agreed to a $124 million settlement over claims of kickbacks to nursing homes in the form of price breaks on certain drugs, the U.S. Department of Justice announced Wednesday.
Charges that Omnicare forgave nursing providers' debts as a form of kickbacks can proceed, judge rulesJune 17, 2014
A whistleblower can pursue charges that long-term care pharmacy Omnicare ignored skilled nursing companies' overdue bills in exchange for certain kinds of business, a federal district court recently ruled.
MDI Achieve/MatrixCare announced it has achieved certification of integration with Omnicare using the NCPDP 10.6 standard, which will let clients reduce medication errors and increase efficiency.
Proper and effective medication management of controlled substances can save your facility thousands of dollars in needless waste and diversion. Most solutions are, figuratively speaking, right under your nose if you know where and how to look. Learn how to protect this valued asset, as well as your staff and residents.
Charges that Omnicare disguised nursing home kickbacks as charitable contributions can proceed, federal judge rulesApril 22, 2014
A whistleblower can keep pursuing his allegations that long-term care pharmacy Omnicare funneled payments to nursing home owners through so-called charitable donations, U.S. District Court Judge Robert M. Dow Jr. recently ruled. Dow dismissed other charges leveled in the suit.
A recent $4 million legal settlement over kickbacks for anemia drug Aranesp is small change compared to other recent deals Omnicare has made with federal authorities. News of these payouts hasn't escaped long-term care pharmacy investors, some of whom filed their own charges against the pharmacy provider, launching a case that is now set to be heard by the U.S. Supreme Court.
Supreme Court to decide whether Omnicare made illegal false statements to investors about nursing home kickbacksMarch 06, 2014
The U.S. Supreme Court will hear a case alleging that the nation's largest long-term care pharmacy, Omnicare, broke the law by keeping potential investors in the dark about kickbacks to nursing homes, the high court announced Monday.
Omnicare reaches $4 million settlement over charges of receiving kickbacks for putting SNF residents on AranespMarch 03, 2014
Omnicare, the nation's largest long-term care pharmacy, has reached a $4 million settlement agreement over allegations that the company conspired with a pharmaceutical company to switch nursing home residents to the anemia drug Aranesp, the U.S. Department of Justice announced Friday.
A whistleblower exposed disturbing drug packaging practices being used by long-term care pharmacy Omnicare Inc., but the charges don't fall under the False Claims Act, a federal appeals court recently ruled.
Pharmaceuticals giant Johnson & Johnson and some subsidiaries will pay more than $2.2 billion to settle claims that they inappropriately promoted antipsychotic drugs for use in nursing homes. The agreement also will settle kickback charges related to the nation's largest long-term care pharmacy, Omnicare.
Two big reactions hit me when news of Johnson & Johnson's $2.2 billion Risperdal settlement with the government landed this week. First, J&J probably made a lot more than it's paying out and, second, some individual probably is going to cash a nice paycheck for bringing it all to light.
Pharmaceuticals giant Johnson & Johnson and some subsidiaries will pay more than $2.2 billion to settle claims that they inappropriately promoted antipsychotic drugs for use in nursing homes, the U.S. Department of Justice announced Monday. The agreement is one the largest ever of its kind, and will also settle charges that the companies paid kickbacks to the nation's largest long-term care pharmacy, Omnicare.
Omnicare, the nation's largest provider of long-term care pharmacy services, has agreed to pay $120 million to settle a False Claims Act lawsuit over Medicare Part A drug pricing, the company announced Wednesday. The settlement likely is one of the largest in a whistleblower case in which the government did not intervene, according to Frederick Morgan, one of Gale's attorneys at the firm Morgan Verkamp LLC.
Omnicare, the nation's largest long-term care pharmaceutical services provider, is positioned to be successful as insurance coverage expands under the Affordable Care Act, according to CEO John Workman.
Two former nursing home executives have agreed to pay $5 million to settle a whistleblower lawsuit involving long-term care pharmacy giant Omnicare Inc., according to the Chicago Tribune.
Kindred Healthcare will split with PharMerica and instead partner with Omnicare in 2014, marking a significant change in the landscape of long-term care pharmacy services providers.
A whistleblower who alleges Omnicare Inc. paid kickbacks to nursing homes did not violate the False Claims Act, a judge has ruled.
Two nursing home operators are set to stand trial to face whistleblower allegations that Omnicare Inc. paid them kickbacks during its purchase of Total Pharmacy.